Search

everythinglearnresearchcommunity

for

Search:↓

Activating mitophagy may help manage a key immune response involved in the hair loss condition alopecia areata.

Genetic variants in specific genes cause central centrifugal cicatricial alopecia.

TGase 3 helps build hair structure by forming strong bonds between proteins.

Semecarpus anacardium leaf extracts may offer safe, effective cancer treatment alternatives.

CMG2 and TEM8 receptors have distinct roles in skin and growth disorders, affecting collagen breakdown and growth.

Mutations in Gasdermin A3 cause skin inflammation and hair loss by disrupting mitochondria.

Matriptase is highly active in hair follicles and sebaceous glands, especially during hair growth phases.

Blocking YAP/TAZ could be a new way to treat skin cancer.

KAP6 genes are conserved across species and active in hair follicles.

IL-19 and IL-24 help cells respond to DNA damage and could be targeted for cancer and age-related disease treatments.

CRISPR/Cas9 has improved precision and control but still faces clinical challenges.

WNT7A gene expression is higher in early stages of androgenetic alopecia, showing the role of WNT pathway, apoptosis, and inflammation in the disorder.

Wedelolactone selectively kills prostate cancer cells without harming normal cells.

pCLCA2 protein may help maintain skin structure and function.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.

A new genetic mutation in the CAST gene may link PLACK syndrome to alopecia areata.

Loss of Ten1 in mice causes telomere shortening and symptoms similar to human dyskeratosis congenita.

Asiasari radix extract may be a potential treatment for melanoma because it selectively triggers cell death in melanoma cells by affecting p53 regulation.

Cells in hair die by breaking down their DNA and mitochondria as they form keratin.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

The study concludes that certain domains in Clostridium histolyticum enzymes are structurally unique, bind calcium to become more stable, and play distinct roles in breaking down collagen, with potential applications in medicine and drug delivery.

Scientists created a cell model to study and find treatments for a skin disease called RDEB.

Protein kinase C epsilon may promote skin cancer development after UV exposure by affecting nearby cells.

Proteolytic enzymes damaged hair follicle stem cells in transgenic mice.

Lack of cystatin M/E causes thin hair and dry skin.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

CircAGK affects cell death in hair cells by controlling the miR-3180-5p/BAX pathway, which can lead to hair loss.

Carriers of a specific gene mutation have subtle skin changes without visible symptoms.